PhenixFIN (NYSE:PFX) Stock Price Passes Below 200-Day Moving Average of $35.36

Shares of PhenixFIN Co. (NYSE:PFXGet Rating) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $35.36 and traded as low as $34.94. PhenixFIN shares last traded at $34.94, with a volume of 312 shares changing hands.

PhenixFIN Price Performance

The company has a market capitalization of $73.02 million, a PE ratio of -30.92 and a beta of 1.18. The firm has a fifty day moving average of $36.06 and a two-hundred day moving average of $35.36. The company has a current ratio of 3.83, a quick ratio of 3.83 and a debt-to-equity ratio of 0.60.

Insider Activity at PhenixFIN

In related news, Director Howard Amster bought 1,850 shares of the company’s stock in a transaction that occurred on Tuesday, February 28th. The stock was bought at an average cost of $38.60 per share, for a total transaction of $71,410.00. Following the acquisition, the director now directly owns 232,888 shares of the company’s stock, valued at approximately $8,989,476.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 20.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On PhenixFIN

Hedge funds have recently modified their holdings of the company. Retirement Group LLC purchased a new position in shares of PhenixFIN in the fourth quarter valued at about $53,000. UBS Group AG increased its position in shares of PhenixFIN by 243.9% in the third quarter. UBS Group AG now owns 2,084 shares of the company’s stock valued at $73,000 after acquiring an additional 1,478 shares during the period. Finally, Adalta Capital Management LLC increased its position in shares of PhenixFIN by 6.2% in the fourth quarter. Adalta Capital Management LLC now owns 118,973 shares of the company’s stock valued at $3,697,000 after acquiring an additional 6,893 shares during the period. Hedge funds and other institutional investors own 27.76% of the company’s stock.

PhenixFIN Company Profile

(Get Rating)

Medley Capital Corporation is a non-diversified closed-end management investment company. The Company’s investment objective is to generate current income and capital appreciation by lending directly to privately-held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions.

Featured Articles

Receive News & Ratings for PhenixFIN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhenixFIN and related companies with's FREE daily email newsletter.